The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) was $17.04 for the day, down -5.65% from the previous closing price of $18.06. In other words, the price has decreased by -$5.65 from its previous closing price. On the day, 0.44 million shares were traded. CNTA stock price reached its highest trading level at $18.97 during the session, while it also had its lowest trading level at $16.89.
Ratios:
Our analysis of CNTA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 21.52 and its Current Ratio is at 21.52. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on September 20, 2024, Upgraded its rating to Overweight and sets its target price to $26 from $11 previously.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $33.
On July 18, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.Oppenheimer initiated its Outperform rating on July 18, 2024, with a $14 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 06 ’24 when SAHA SAURABH sold 87,496 shares for $18.46 per share. The transaction valued at 1,615,255 led to the insider holds 575,661 shares of the business.
SAHA SAURABH bought 87,496 shares of CNTA for $1,615,255 on Dec 06 ’24. On Nov 25 ’24, another insider, SAHA SAURABH, who serves as the Chief Executive Officer of the company, sold 299 shares for $18.23 each. As a result, the insider received 5,451 and left with 575,661 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 2381135616 and an Enterprise Value of 1538217472. For the stock, the TTM Price-to-Sale (P/S) ratio is 324.67 while its Price-to-Book (P/B) ratio in mrq is 4.49. Its current Enterprise Value per Revenue stands at 224.459 whereas that against EBITDA is -9.536.
Stock Price History:
Over the past 52 weeks, CNTA has reached a high of $18.92, while it has fallen to a 52-week low of $6.15. The 50-Day Moving Average of the stock is 3.62%, while the 200-Day Moving Average is calculated to be 38.68%.
Shares Statistics:
CNTA traded an average of 684.13K shares per day over the past three months and 579140 shares per day over the past ten days. A total of 131.66M shares are outstanding, with a floating share count of 89.08M. Insiders hold about 32.34% of the company’s shares, while institutions hold 51.12% stake in the company. Shares short for CNTA as of 1732838400 were 3345785 with a Short Ratio of 3.56, compared to 1730332800 on 2147348. Therefore, it implies a Short% of Shares Outstanding of 3345785 and a Short% of Float of 3.1199999999999997.
